[250 Pages Report] The tissue sealants and tissue adhesive market is anticipated to register a CAGR of 8.4% during the forecast period, up from US$ 1,509.6 Million in 2021 to reach a valuation of US$ 2,876.9 Million by 2027.
| Report Attributes | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 1,509.8 Million |
| Anticipated Forecast Value (2027) | US$ 2,876.9 Million |
| Projected Growth Rate (2022 to 2032) | 8.4% CAGR |
Sales of tissue sealants and tissue adhesives are expected to decline as key companies in the market are employing them to rebuild peripheral nerves.
In addition to this, demand for tissue sealants and tissue adhesive is rising because bone-related disorders are expected to propel the growth of the global tissue glue and bio-adhesive sealants market over the forecast period.
For instance, according to the paper 'New Osteoporotic/Vertebral Compression Fractures', published in 2018 by National Center for Biotechnology Information (NCBI), the U.S. records 700,000 cases of vertebral compression fractures annually.
Increasing R&D in tissue glue and bio-adhesive sealants is also projected to contribute to the growth of the tissue sealants and tissue adhesive market share.
The report sheds light on the factors improving the sales of tissue sealants and tissue adhesive and, in turn, the opportunities for the market players. However, the tissue sealants and tissue adhesive market also face some challenges, which might limit the tissue sealants and tissue adhesive market share from reaching its potential.
Some of the key tissue sealants and tissue adhesive market trends promoting the demand for tissue sealants and tissue adhesive include being employed by key companies to rebuild peripheral nerves.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The tissue sealing and tissue adhesive market are driven by increasing sales of tissue sealants and tissue adhesive products among surgeons due to their efficacy in preventing bleeding during surgery.
These tissue sealants diminish post-operative bleeding. In addition, these tissue sealants are highly effective, easy to use and less prone to microbial infection after surgery.
Factors such as aging the population and rising surgical procedures result in the increased demand for Tissue sealing and tissue adhesive globally.
The stringent regulatory policies and high cost of the products are major restraints of the sales of tissue sealants and tissue adhesive.
The global tissue sealants and tissue adhesive market is predicted to profit from the rising demand for tissue sealants and tissue adhesive number of operations and amputations.
The growth in the number of arthroplasty surgeries is also likely to help expand the sales of tissue sealants and tissue adhesive.
Depending upon the geographic regions global tissue sealants and adhesives market is segmented into seven key regions-North America, Latin America, Eastern Europe, Western Europe, and the Asia Pacific, excluding Japan, Japan, Middle East and Africa.
North America dominates global sales of tissue sealants and tissue adhesive due to the significant spending power of the population and technological advancement. However, Asia Pacific countries are anticipated to witness lucrative growth in demand for tissue sealants and the tissue adhesive market.
Increasing demand for tissue sealants and tissue adhesive market will be driven by increased investments in healthcare infrastructure and state-of-the-art medical research facilities in the Middle East and Africa during the forecast period, as well as a growing population, improved life expectancy, and increased awareness among both patients and physicians regarding available treatment options.
Government-driven price management and reimbursement limits are becoming more common in the APAC region, notably in China and Japan. At the same time, the South American sector remains undeveloped due to a lack of knowledge and price sensitivity in the sales of tissue sealants and adhesives.
Principal Consultant
The key players in the global tissue sealants and tissue adhesive market are Baxter International Inc., Johnson & Johnson, Exapharma, Smith & Nephew, C.R Bard and Integra LifeSciences.
The sales of tissue sealants and tissue adhesive is led by Johnson & Johnson (Ethicon, Inc.) (US). The corporation has a well-known brand and a significant regional presence.
It has a robust and diverse product range for surgical sealants and adhesives, including some of the most well-known names.
The report consists of key players contributing to tissue sealants and tissue adhesive market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyses the competitive landscape and the market share of tissue sealants and tissue adhesive by players to strengthen their market position.
Key participants in the sales of tissue sealants and tissue adhesive are focusing on product development and approval to grow their product range. Polygamic, for example, acquired CE certification for LIQOSEAL, an easy-to-use and novel dural sealant patch, in January 2020.
Sales of tissue and tissue Adhesu Market participants are increasingly adopting inorganic operations. CryoLife, Inc., for example, teamed with Misonix in December 2019 to commercialize CryoLife's NeoPatch product for the treatment of a variety of diseases outside of cardiac and vascular surgery.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 8.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Application, End user Region, |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific; Japan; Middle East and Africa |
| Key Countries Profiled | USA; Canada; Mexico; Brazil; Germany; Italy; UK; Spain; France; Russia; China; India; ASEAN; Australia & New Zealand; Japan; GCG; South Africa |
| Key Companies Profiled | Baxter International Inc.; Johnson & Johnson; Exapharma; Smith & Nephew; C.R Bard and Integra LifeSciences |
| Customization Scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
The tissue sealants and tissue adhesive market is anticipated to register a CAGR of 8.4% during the forecast period.
Key players holding substantial market share include Baxter International Inc., Johnson & Johnson, Exapharma, Smith & Nephew, C.R Bard, and Integra Life Sciences.
As per the analysis, the tissues sealants and tissue adhesive market share is likely to be US$ 2876.9 Mn by 2027.
Demand for tissue sealants and tissue adhesive is likely to rise on the back of sales of tissue sealants and tissue adhesive products among surgeons due to its efficacy to prevent bleeding during surgery.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Bn) Analysis By Product, 2017-2021
5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product, 2022-2032
5.3.1. Tissue Adhesives
5.3.2. Tissue Sealants
5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2022-2032
6.3.1. Surgical Procedures
6.3.2. Trauma Cases
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Bn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Clinics
7.3.4. Emergence Medical Services
7.3.5. Long Term Care Centers
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.K.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia & Pacific Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Indonesia
13.2.1.4. Malaysia
13.2.1.5. Singapore
13.2.1.6. Australia
13.2.1.7. New Zealand
13.2.1.8. Rest of South Asia & Pacific
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. MEA Tissue Sealants and Tissue Adhesive Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Key Countries Tissue Sealants and Tissue Adhesive Market Analysis
15.1. U.K.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product
15.1.2.2. By Application
15.1.2.3. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product
15.2.2.2. By Application
15.2.2.3. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product
15.3.2.2. By Application
15.3.2.3. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product
15.4.2.2. By Application
15.4.2.3. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product
15.5.2.2. By Application
15.5.2.3. By End User
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product
15.6.2.2. By Application
15.6.2.3. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product
15.7.2.2. By Application
15.7.2.3. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product
15.8.2.2. By Application
15.8.2.3. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product
15.9.2.2. By Application
15.9.2.3. By End User
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product
15.10.2.2. By Application
15.10.2.3. By End User
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product
15.11.2.2. By Application
15.11.2.3. By End User
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product
15.12.2.2. By Application
15.12.2.3. By End User
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product
15.13.2.2. By Application
15.13.2.3. By End User
15.14. Thailand
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product
15.14.2.2. By Application
15.14.2.3. By End User
15.15. Indonesia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product
15.15.2.2. By Application
15.15.2.3. By End User
15.16. Malaysia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product
15.16.2.2. By Application
15.16.2.3. By End User
15.17. Singapore
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product
15.17.2.2. By Application
15.17.2.3. By End User
15.18. Australia
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product
15.18.2.2. By Application
15.18.2.3. By End User
15.19. New Zealand
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product
15.19.2.2. By Application
15.19.2.3. By End User
15.20. GCC Countries
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product
15.20.2.2. By Application
15.20.2.3. By End User
15.21. South Africa
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Product
15.21.2.2. By Application
15.21.2.3. By End User
15.22. Israel
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2021
15.22.2.1. By Product
15.22.2.2. By Application
15.22.2.3. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Smith & Nephew
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Baxter International, Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Ethicon US, LLC.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. B. Braun Medical, Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. C.R Bard, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Cryo Life
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Medtronic
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Advanced Medical Solutions Group plc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Equimedical
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. CSL Behring
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Tissue Sealants and Tissue Adhesive Market
